NP564526.RA4k1ba1-TaIdA3v-SjrQmF-AR O7qSeya-T GbLWXofM
has assertion: NP564526.RA4k1ba1-TaIdA3v-SjrQmF-AR O7qSeya-T GbLWXofM130 assertion
has provenance: NP564526.RA4k1ba1-TaIdA3v-SjrQmF-AR O7qSeya-T GbLWXofM130 provenance
has publication info: NP564526.RA4k1ba1-TaIdA3v-SjrQmF-AR O7qSeya-T GbLWXofM130 publicationInfo
type: Nanopublication
created: 2016-05-13T12:46:01+02:00
rights: http://opendatacommons.org/licenses/odbl/1.0/
rights holder: IBIGroup
subject: SIO_000983
used data: disgenetv3.0rdf
authored by: http://orcid.org/0000-0001-5999-6269
authored by: http://orcid.org/0000-0002-7534-7661
authored by: 0000-0002-9383-528X
authored by: http://orcid.org/0000-0003-0169-8159
authored by: http://orcid.org/0000-0003-1244-7654
created by: http://orcid.org/0000-0003-0169-8159
version: v4.0.0.0

NP564526.RA4k1ba1-TaIdA3v-SjrQmF-AR O7qSeya-T GbLWXofM130 assertion
type: Assertion
description: [Whereas KIT juxtamembrane domain mutations seen in most patients with GIST are highly sensitive to imatinib, the kinase activation loop mutant D816V, frequently encountered in SM, hampers the binding ability of imatinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
evidence: DisGeNET evidence - LITERATURE
SIO_000772: http://identifiers.org/pubmed/16912224
was generated by: ECO_0000203

befree-2016
imported on: 2016-02-19

DisGeNET evidence - LITERATURE
type: ECO_0000212
comment: Gene-disease associations inferred from text-mining the literature.

disgenetv3.0rdf
version: v4.0.0